Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cardio-Renal I FINAL > Therapeutics - Cassagnol Heart Failure Part 1 > Flashcards

Therapeutics - Cassagnol Heart Failure Part 1 Flashcards

1
Q

what are the 2 drugs in entresto

A

sacubitril (neprilysin inhibitor) + valsartan (ARB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

explain how sacubitril works in heart failure patients

A

inhibits neprilysin

normally, neprilysin is a peptide responsible for breaking down NATRIURETIC PEPTIDE

this isnt good because in cases of hypervolemia (heart failure) natriuretic peptide is released by the stretching heart, which travels to the kidneys, to cause the excretion of sodium and water

so we inhibit neprilysin with sacubitril – in hopes to INCREASE THE HALF LIFE of natriuretic peptide and help with volume control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why is sacubitril given with an ARB??

why not with an ACE inhibitor?

A

increased renin levels cause natriuretic peptide not to work as well – so we give an ARB which antagonizes renin, + sacubitril which inhibits neprilysin – all of this helps to increase the effect of natriuretic peptide

sacubitril cant be given with an ACE inhibitor due to the risk of angioedema. both neprilysin and ACE breakdown bradykinin – so giving an inhibitor of both can cause a accumulation of bradykinin which significantly increases the risk of angioedema

NEED WASHOUT PERIOD BETWEEN ACE INHIBITOR AND ARNI!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is considered first line therapy for ALL heart failure in stage C

A

ARNI (entresto) is preferred, but ACE inhibitors and ARBS are also 1st line

also mineralocorticoid antagonists, SGL-2i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is considered a first line therapy for HFrEF ONLY in stage C

A

beta blockers – specifically carvedilol, metoprolol SUCCINATE, and bisoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain the regimen for entresto (stage c) if the patient has previously been on over 10mg enalapril/ over 10 of lisinopril/ over 5 of ramipril

A

give an initial dose of 49/51mg BID

double the dose after 2-4 weeks – -target dose of 97mg/103mg – shown to have max benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

explain the regimen for entresto (stage C) if the patient HAS NOT previously been on an ACE inhibitor, or has been on one but at a low dose (less than 10mg enalapril, less than 10mL lisinopril, less than 5mL ramipril)

A

initial dose of 24mg/26mg BID

double dose after 2-4 weeks to 49/51mg BID

2-4 more weeks – try to get to goal of 97mg/103mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TRUE OR FALSE

ARNI + ACE inhibitor is a contraindication

A

TRUE - risk of angioedema

NEEDS A WASHOUT PERIOD OF 36 HOURS!!!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ARNI should NOT be administered to patients with a history of….

A

angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

monitoring parameters for ARNI

A

blood pressure
efficacy, hospital visits, etc
angioedema
dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

4 scenarios in which ACE inhibitors/ARBS should be used with caution in heart failure patients

A

-hypotensive (BP under 80)
-SCr over 3
-bilateral renal artery stenosis (poor perfusion, risk of AKI)

-serum POTASSIUM over 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

general ACE/ARB dosing strategy for stage C heart failure

A

initiate low doses and titrate SLOWLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

explain the monitoring parameters for ace inhibitors and arbs

A

renal fxn and potassium should be monitored within 2 weeks of initiation in patients at risk for more toxicities

also – check BMP after 2-4 weeks and if everything normal – titrate dose up – and repeat until target dose is reached

monitor potassium, creatinine, BP, cough and angioedema (ACE inhibitor)
only rly check Mg if K abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

counseling point for ACE/ARB patients

A

watch how much potassium you take in diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

**patient presents to ER in acute heart failure exacerbation and is hypervolemic.
they have never been on a beta blocker. should you initiate one?

A

NOOOOOOOOOOOOO

this can cause cardiac suppression and make their heart failure WORSE

HAVE TO WAIT until the patient becomes euvolemic and is under volume control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

**patient presents to ER with a heart failure exacerbation and they are currently on a beta blocker.
should you keep them on ?

A

YES — NEVER ABRUPTLY STOP BETA BLOCKERS
will cause reflex tachycardia which is very bad for a failing heart

DO NOT TOUCH THE BETA BLOCKER IS THEY ARE TAKING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

monitoring parameters for beta blockers

A

heart rate
blood pressure (mostly carvedilol bc alpha blocker)
fluid retention (worsening HF)
fatigue (mainly metoprolol succinate)
heart block
bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

as mentioned, it’s possible that patients on beta blockers can experience fluid retention and worsening heart failure

what is done in this case?

A

we may need to decrease the dose to make the patient more tolerant

if this doesnt work, may need to permanently add a diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2 mineralocorticoid antagonists that are considered 1st line for all heart failure

how do they work to treat heart failure?

A

spironolactone
eplerenone

used for their aldosterone antagonism

in heart failure, aldosterone levels are high. these will bind to receptors on the heart, causing fibrotic growth on the heart and permanent morphological changes – want to prevent this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

3 specific lab values to monitor for mineralocorticoid antagonists

A

BUN, SCr, K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

explain the monitoring schedule for mineralocorticoid antagonists

A

3 days after initiating
1 week later
2 weeks later – continue every 2 weeks until STABLE and keep that dose

then, every 2-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

mineralocorticoid antagonists are CONTRAINDICATED in creatinine clearance of….

A

less than 30mL/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

mineralocorticoid antagonists are contraindicated in potassium levels over….

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

creatinine levels over ___ in men and ___ in women means a contraindication for mineralocorticoid antagonists

A

over 2.5 in men and over 2 in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

counseling point for patients on mineralocorticoid antagonists

A

watch potassium intake!!!!

26
Q

true or false

mineralocorticoid antagonists do not affect renal function

A

false -they do

contraindicated in eGFR less than 30

27
Q

name 2 SGLT2 inhibitors

are they first line?

what is starting dose?

A

dapagliflozin and empagliflozin

first line for all heart failure - diabetic or not (stage c) and a and b for diabetics

starting dose and target dose for both is 10mg daily

28
Q

side effects and clinical considerations of SGLT2 inhibitors

A

increased urination (not a diuretic, but diuretic effect)

increased risk UTI bc glucose in urine

dizziness, dehydration

DIABETIC KETOACIDOSIS

also, hold the med for 3 days prior to a major surgery or prolonged fasting period - risk of euglycemic ketoacidosis

29
Q

special consideration for dapagliflozin

A

if eGFR less than 30 — do NOT give this drug

if they’ve already been taking tho - can continue if tolerated

30
Q

monitoring parameters for SGLT2 inhibitors

A

blood pressure
kidney fxn
volume and fasting status

31
Q

in heart failure, when are diuretics given?

A

can be as needed for fluid overload, or chronically (ie - with a beta blocker to increase pt’s tolerance)

32
Q

which diuretics are first line

A

loop

33
Q

***role of thiazides in heart failure

A

as an ADJUVANT – only given to patients who show resistance to loops (ie - you keep upping the loop dose, but still no urine outpu)

34
Q

pt counseling point when on thiazide + loop (when to take)

A

give thiazide 30 min before loop

35
Q

name 4 loop diuretics

A

bumetanide
furosemide

torsemide
ethacrynic acid

36
Q

true or false

diuretics in heart failure do NOT increase mortality

A

true – they really just help with the pt’s symptoms

37
Q

when to use HCTZ vs metolazone

A

HCTZ cannot be used in CrCl less than 30 — can use metolazone at crcl up to 5

38
Q

advantage of ethacrynic acid over the other loops

A

has activity at PCT and DCT AND can be used in patients with sulfonamide allergy

39
Q

goal diuresis when giving diuretics per day

A

0.5-2lITERS – but this changes with age

target would be on the lower end for older patients

40
Q

3 AE of diuretics

A

azotemia (elevated BUN)
hypokalemia
metabolic alkalosis (bc ascending loop involved with acid-base control)

41
Q

specific monitoring parameters for thiazides

A

WEIGHT
potassium
creatinine
magnesium

~1-2 weeks after initiating

42
Q

BUN: creatinine ratio should be….

A

20 or less

greater than 20 = azotemia – excess wastes in the blood

43
Q

name 2 vasodilators that can be used in heart failure

A

hydralazine
isosorbide dinitrate

44
Q

can hydralazine and isosorbide dinitrate be used together?

A

YES

45
Q

hydralazine/dinitrate should ALWAYS be combined with…..

A

mild diuretic and beta blocker

usually used in combo with ACE/ARNI/ARB — but can also be used if the pt has some contraindication to these

46
Q

side effects of hydralazine/isosorbide dinitrate

A

headache, dizziness
GI complaints

47
Q

2 monitoring parameters for hydralazine/isosorbide dinitrate

A

blood pressure
rash (hydralazine)

48
Q

true or false

ACE/ARB/ARNI should be tried before hydralazine/dinitrate

A

true

49
Q

3 parameters that MUST BE MET in order to initiate ivabradine

is this the same for digoxin

A

-normal sinus rhythm
-heart rate over 70 bpm
-on a beta blocker

for digoxin –
-can be with OR without beta blocker
-dont need normal sinus rhythm
(i think heart rate still has to be over 70 bpm tho?)

50
Q

true or false

ivabradine does NOT reduce mortality

A

true

only morbidity (hospitalizations)

51
Q

target heart rate when giving ivabradine
what is max dose?

A

50-60bpm

max dose is 7.5mg BID

52
Q

monitoring for ivabradine

A

HEART RATE

53
Q

ivabradine is mostly used for which type of heart failure

A

HFrEF

54
Q

target serum digoxin levels

A

0.5- less than 9mg/dL

if goes over 1.2, mortality increases significantly

55
Q

true or false

a loading dose is necessary for digoxin when giving in heart failure

A

FALSE - not necessary

56
Q

monitoring for digoxin

A

digoxin toxicity - GI and CNS effects

renal function
LOT of drug and food interactions
heart rate!

57
Q

when should the digoxin levels be measured

A

at steady state (3 or more doses) at least 6 hours after the dose was given

58
Q

does digoxin reduce mortality

A

NO - like ivadbradine - reduce hospitalizations AND also used for HFrEF

59
Q

furosemide IV:PO
bumetanide IV:PO

A

furosemide: 2:1 (40MG po -> 40MG IV = double the dose)

bumetanide: 1:1

60
Q

explain the type of patient that is given digoxin

A

patients with persistent SYMPTOMS (late stage C)
in AV block

NOT considered 1st line

61
Q
A

Cardio-Renal I FINAL (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions